AbbVie today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia who are experiencing an acute ...

Sen. Elizabeth Warren (D-Mass.) said Monday that President elect-Trump “and his transition team are already breaking” a law ...

Froedtert ThedaCare Health celebrates topping-out ceremony for new Oshkosh medical campus "They say that what you do for ...

Detailed price information for Bioxcel Therapeutics Inc (BTAI-Q) from The Globe and Mail including charting and trades.

Door-to-door sales agents targeted the elderly with promises of energy savings, rebates, tax credits that proved illusory, an ...

Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...